Category Archive: Forbes

Medicare Mythbuster: “I Must Enroll In Medicare At Age 65”?!

Many people thinking about Medicare enrollment experience stress. Adding to that stress is a variety of Medicare myths and misunderstandings. Perhaps one of the biggest myths is “I must enroll in Medicare at age 65, no matter what.”

Medicare Mythbuster: “I Must Enroll In Medicare At Age 65”?!

Many people thinking about Medicare enrollment experience stress. Adding to that stress is a variety of Medicare myths and misunderstandings. Perhaps one of the biggest myths is “I must enroll in Medicare at age 65, no matter what.”

Cystic Fibrosis: How Gunnar Esiason Is Making A Difference

Cystic Fibrosis (CF) is a fatal and progressive genetic disorder that affects the lungs and pancreas. It results in persistent lung infections–due to production of thick mucous–which also impair the ability to breathe. I recently spoke with Gunnar …

Cystic Fibrosis: How Gunnar Esiason Is Making A Difference

Cystic Fibrosis (CF) is a fatal and progressive genetic disorder that affects the lungs and pancreas. It results in persistent lung infections–due to production of thick mucous–which also impair the ability to breathe. I recently spoke with Gunnar …

Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure

Diabetes patients’ cost-sharing is increasing as PBMs and health plans are paying less for insulin products. While this situation defies logic, it reflects an imperfect market in which it’s not necessarily in the PBMs’ and health plans’ interests to en…

This Museum Is Adding A Permanent Exhibit Featuring Art About Health And Medicine

After twelve years, the Wellcome Collection in London is updating its permanent exhibit on health and medicine. The “Medicine Now” display will close in April and a new exhibit will take its place in September.

How Will The Failure Of Biogen’s Alzheimer’s Drug, Aducanumab, Impact R&D?

The death of an important drug like aducanumab will have both a short and a long term effect on Biogen as a company and especially on R&D.

How Will The Failure Of Biogen’s Alzheimer’s Drug, Aducanumab, Impact R&D?

The death of an important drug like aducanumab will have both a short and a long term effect on Biogen as a company and especially on R&D.

10 Tools For Fighting Aflatoxin, Which Causes Liver Cancer And Childhood Stunting

Soil treatment, investments in biodiversity, climate change mitigation, improved food handling, crowdsourced science, and more.

The Alarming Child Poverty Risk In Spain Despite The Economic Recovery

After a critical period of recession that lasted until 2013, little by little, the Spanish economy has managed to heal from the ravages of the crisis. The figures, however, are far from reflecting the reality of many families and, more specifically, ma…

Older posts «

Explore the Archive